Depreciation in USD of Alzamend Neuro, Inc. from 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Alzamend Neuro, Inc. quarterly/annual Depreciation history and growth rate from 2021 to Q2 2025.
  • Alzamend Neuro, Inc. Depreciation for the quarter ending July 31, 2025 was $27.7K, a 118% increase year-over-year.
  • Alzamend Neuro, Inc. annual Depreciation for 2024 was $50.7K, unchanged from 2023.
  • Alzamend Neuro, Inc. annual Depreciation for 2023 was $50.7K, a 120% increase from 2022.
  • Alzamend Neuro, Inc. annual Depreciation for 2022 was $23.1K, a 550% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Alzamend Neuro, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $27.7K +$15K +118% May 1, 2025 Jul 31, 2025 10-Q 2025-09-10
Q2 2024 $12.7K $0 0% May 1, 2024 Jul 31, 2024 10-Q 2025-09-10
Q2 2023 $12.7K +$5.59K +78.7% May 1, 2023 Jul 31, 2023 10-Q 2024-09-11
Q2 2022 $7.1K May 1, 2022 Jul 31, 2022 10-Q 2023-09-13

Alzamend Neuro, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $50.7K $0 0% May 1, 2024 Apr 30, 2025 10-K 2025-07-22
2023 $50.7K +$27.7K +120% May 1, 2023 Apr 30, 2024 10-K 2025-07-22
2022 $23.1K +$19.5K +550% May 1, 2022 Apr 30, 2023 10-K 2024-07-30
2021 $3.55K May 1, 2021 Apr 30, 2022 10-K 2023-07-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.